Holly Tao

Holly Tao is a senior associate in White & Case's Global Antitrust/Competition practice. She represents leading companies in complex litigations on issues at the forefront of antitrust and intellectual property law. Holly works with clients across a broad range of industries, including pharmaceuticals, technology, financial services, and consumer and retail.

A significant part of Holly's practice focuses on the competition-risk issues of innovator companies. She is regularly a core member of teams representing global pharmaceutical and technology companies in antitrust, patent, and licensing and contractual disputes, as well as in government investigations on competition-related conduct. Holly has litigated nationwide, antitrust class-action lawsuits on behalf of pharmaceutical clients, and cases arising under the Biologics Price Competition and Innovation Act and the Hatch-Waxman Act. She counsels life sciences companies on patent invalidity and infringement issues.

Holly is also active in the Firm's pro bono work. She represents individuals and organizations at both trial and appellate courts, and has litigated matters regarding US constitutional rights as well as cases brought under Title VII of the Civil Rights Act and the Individuals with Disabilities Education Act.